Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial

Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial

Background/Aims: Cardiac biomarkers are associated with cardiac abnormalities and adverse outcomes in dialysis patients. Our aim was to report the effect of the beta-blocker carvedilol on cardiac biomarkers in adult dialysis patients. Methods: The Beta-Blocker to Lower Cardiovascular Dialysis Events...

Full description

Bibliographic Details
Main Authors: Matthew A. Roberts, Darsy Darssan, Sunil V. Badve, Robert P. Carroll, Magid A. Fahim, Brian A. Haluska, Carmel M. Hawley, Nicole M. Isbel, Mark R. Marshall, Elaine M. Pascoe, Eugenie Pedagogos, Helen L. Pilmore, Paul Snelling, Tony Stanton, Ken-Soon Tan, Andrew M. Tonkin, Liza A. Vergara, Francesco L.  Ierino
Format: Article
Language:English
Published: Karger Publishers 2017-12-01
Series:Kidney & Blood Pressure Research
Subjects:
Beta-adrenergic receptor blocker
Cardiac biomarkers
Cardiovascular
Dialysis
Echocardiography
Randomized controlled trial
Online Access:https://www.karger.com/Article/FullText/485589

Internet

https://www.karger.com/Article/FullText/485589

Similar Items